Hatch-Waxman and eDiscovery: Turbo-Charging Pharma Collections and Reviews

Navigating Hatch-Waxman legislation can be complex and challenging from legal, regulatory, and eDiscovery perspectives. The stakes are high for both brand name and generic pharmaceutical manufacturers as timing and ability to act swiftly in application submissions and responses many times mean the difference between market success or undesired outcomes.

In this presentation, expert eDiscovery technologists and authorities will share information, insight, and proven best practices for planning and supporting time-sensitive pharmaceutical collections and reviews so Hatch-Waxman requirements are your ally and not your adversary on the road to legal and business success.